The latest financial statement is for the year ending 2025-12-31.
| Cash Flow | 2025-12-31 |
|---|---|
| Loss on debt extinguishment, net | 0 |
| Realized gain on short-term investments | 0 |
| Issuance of common stock for licensing right | 0 |
| Amortization of debt discount | 0 |
| Loss on issuance of warrants | 0 |
| Compensation expense recognized for the issuance of shares and warrants in connection with the sale of a previously controlled subsidiary | 7,000 |
| Gain on debt extinguishment, net | 278 |
| Loss on disposal of crypto holdings | 403 |
| Gain on waiver of accrued interest | -371 |
| Unrealized foreign exchange gain / loss | 16 |
| Loss (gain) on change in fair value of convertible notes payable | -2,737 |
| Gain on change in fair value of warrants | -138 |
| Non-cash lease expense | 125 |
| Stock-based compensation expense | 2,183 |
| Non-cash interest expense | 253 |
| Depreciation expense | 21 |
| Amortization of prepaid directors and officers insurance | 1,440 |
| Amortization expense | 2,404 |
| Issuance of common stock for services | 1,152 |
| Issuance of common stock for services - related party | 2,097 |
| Gain (loss) on issuance of common stock for services | -70 |
| Prepaid expenses and other current assets | 4,062 |
| Accounts payable | 434 |
| Accrued expenses and other current liabilities | 1,114 |
| Accrued litigation liability | 9,594 |
| Lease liability | -125 |
| Net loss | -39,224 |
| Net cash used in operating activities | -15,555 |
| Purchases of short-term investments | 0 |
| Proceeds from the sale of short-term investments | 0 |
| Purchase of digital assets | 1,998 |
| Proceeds from disposal of digital assets | 1,595 |
| Purchase of equipment and clinical assets | 405 |
| Net cash flows used in investing activities | -808 |
| Proceeds from the issuance of notes payable related parties | 0 |
| Exercise of warrants | 0 |
| Proceeds from issuance of warrants | 0 |
| Proceeds from issuance of common shares related to atm program | 19,699 |
| Repayment of notes payable | 158 |
| Repayment of notes payable - related parties | 425 |
| Repayment of convertible notes payable - related parties | 927 |
| Repayment of convertible notes payable | 661 |
| Purchases of treasury stock | 106 |
| Net cash flows provided by financing activities | 17,422 |
| Net change in cash and cash equivalents before effect of exchange rate changes | 1,059 |
| Effect of exchange rate changes on cash and cash equivalents | -104 |
| Net change in cash | 955 |
| Cash and cash equivalents at beginning of year | 554 |
| Cash and cash equivalents at end of year | 1,509 |
CDT Equity Inc. (CDTTW)
CDT Equity Inc. (CDTTW)